In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

Brian Holmes is the first man in the UK and the fifth in the world to receive the treatment.

Prostate enlargement, which is called Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement and is common in ...

For patients with prostate cancer, concurrent use of enzalutamide, apalutamide, or abiraterone with direct oral antico ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants published by Wiley online in CANCER, investigators found ...

An NHS diabetes drug costing as little as 2p per tablet could cut the risk of prostate cancer by more than a third, according to a study.

This article was reviewed by Knox Beasley. Key Takeaways: 1mg oral finasteride effectively treats hair loss and is the ...

A drug which could extend or save the lives of men living with prostate cancer can’t be approved for patients in Northern ...

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

The FDA's cancer advisors will discuss AstraZeneca’s application for the oral SERD camizestrant in breast cancer and the AKT ...